Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lubrication of articular cartilage is not a molecule or receptor, and therefore cannot be treated as a therapeutic target in the traditional sense. It is a complex, multi-modal physiological process or physiological mechanism, not a discrete molecular entity suitable for drug targeting. The lubrication system relies on several distinct molecules and mechanisms working synergistically, including hyaluronic acid (HA), lubricin, proteoglycans (aggrecans), and phospholipids. These components contribute to lubrication mechanisms such as elastohydrodynamic, boundary, weeping, and boosted lubrication, which operate adaptively depending on loading conditions. For therapeutic intervention, focus should be on individual molecular targets involved in this process, such as hyaluronic acid, lubricin, or phospholipids, rather than the overarching process itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lubrication of articular cartilage.